You are here

P&T News

November 14

The less-expensive biosimilar will cut into J&J’s nearly $5 billion annual sales of infliximab
Outcomes Improve for Those With and Without a History of Prior CV Events

November 13

Medication previously approved for acute treatments
Mortality falls in patients when CRP dips in first three months

November 10

First new hepatitis B vaccine in 25 years requires only two doses
New approval covers the most common subtypes of cutaneous T-cell lymphoma

November 9

In first few days, average daily sign-ups nearly double last year
Compared with placebo, depression scores fell at 60 hours
National Safety Council to launch education campaign
Merck drug associated with lower mortality through week 48 post-transplant

November 7

The practice adds to drug resistance in humans and the potential for “superbugs”
Positive phase 3 results comparing alectinib with crizotinib supported approval
Agent treats certain chronic pulmonary infections in patients with cystic fibrosis
Research shows connections between glucose metabolism, Alzheimer’s pathology
Some minorities—particularly African-Americans—remain underrepresented

November 6

Treatment for rare blood disease targets patients with BRAF V600 mutation
Risk of death in advanced cases is 26% lower than Afinitor
Patients with cardiovascular issues benefit

November 3

Topical monotherapy lowers pressure in the eye

Pages